KYAT1
Kynurenine--oxoglutarate transaminase 1
Also known as: CCBL1, GTK, KAT1_HUMAN, KATI
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q16773
- Gene
- KYAT1
- Ensembl
- ENSG00000171097
- Chromosome
- 9
- Canonical length
- 422 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a cytosolic enzyme that is responsible for the metabolism of cysteine conjugates of certain halogenated alkenes and alkanes. This metabolism can form reactive metabolites leading to nephrotoxicity and neurotoxicity. Increased levels of this enzyme have been linked to schizophrenia. Multiple transcript variants that encode different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>Q16773|KYAT1
1 MAKQLQARRL DGIDYNPWVE FVKLASEHDV VNLGQGFPDF PPPDFAVEAF QHAVSGDFML
61 NQYTKTFGYP PLTKILASFF GELLGQEIDP LRNVLVTVGG YGALFTAFQA LVDEGDEVII
121 IEPFFDCYEP MTMMAGGRPV FVSLKPGPIQ NGELGSSSNW QLDPMELAGK FTSRTKALVL
181 NTPNNPLGKV FSREELELVA SLCQQHDVVC ITDEVYQWMV YDGHQHISIA SLPGMWERTL
241 TIGSAGKTFS ATGWKVGWVL GPDHIMKHLR TVHQNSVFHC PTQSQAAVAE SFEREQLLFR
301 QPSSYFVQFP QAMQRCRDHM IRSLQSVGLK PIIPQGSYFL ITDISDFKRK MPDLPGAVDE
361 PYDRRFVKWM IKNKGLVAIP VSIFYSVPHQ KHFDHYIRFC FVKDEATLQA MDEKLRKWKV
421 ELLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KYAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 21 nTPM
- cerebral cortex: 14 nTPM
- basal ganglia: 13 nTPM
- cerebellum: 13 nTPM
- skeletal muscle: 12 nTPM
- liver: 12 nTPM
Single-cell type
- podocytes: 80 nCPM
- choroid plexus epithelial cells: 78 nCPM
- bergmann glia: 55 nCPM
- brain inhibitory neurons: 48 nCPM
- brain excitatory neurons: 43 nCPM
- astrocytes: 38 nCPM
Immune cell
- memory B-cell: 7.7 nTPM
- T-reg: 7 nTPM
- naive CD8 T-cell: 6.8 nTPM
- memory CD8 T-cell: 6.1 nTPM
- naive CD4 T-cell: 5.9 nTPM
- memory CD4 T-cell: 5.8 nTPM
Brain region
- white matter: 24 nTPM
- cerebral cortex: 17 nTPM
- basal ganglia: 15 nTPM
- medulla oblongata: 15 nTPM
- cerebellum: 15 nTPM
- thalamus: 15 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cysteine-S-conjugate beta-lyase activity
- kynurenine-oxoglutarate transaminase activity
- protein homodimerization activity
- pyridoxal phosphate binding
- glutamine-phenylpyruvate transaminase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KYAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KYAT1 as an antibody target. Whether an autoantibody or antibody against KYAT1 could matter depends on whether native KYAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KYAT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KYAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...